El cáncer de endometrio tiene su primer enemigo en España
Un medicamento autorizado por la Comisión Europea se convierte en el primer y único tratamiento inmunooncológico contra el cáncer de
Leer másUn medicamento autorizado por la Comisión Europea se convierte en el primer y único tratamiento inmunooncológico contra el cáncer de
Leer másSe están reclutando pacientes para otros estudios de registro adicionales de dostarlimab en cáncer de recto y cáncer colorrectal GSK
Leer másCookie | Duración | Descripción |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |